Introduction
Cell cycle dysregulation is a critical feature of tumor cells. Numerous cell cycle regulators act either as oncogenes or tumor suppressors, and their aberrations result in proliferative advantage for cancer cells. Protein kinase B (PKB, also called Akt) is the cellular homologue of the oncogene of the AKT8 oncovirus (v-Akt). Akt is activated when particular extracellular signals activate receptor tyrosine kinases to enhance phosphatidylinositide 3-OH kinase (PI3K) activity on phospholipids. The oncogene is a crucial regulator of a variety of cellular processes, including cell survival and proliferation. It promotes survival by phosphorylating Bad (Datta et al., 2000) or the forkhead transcription factor (Brunet et al., 1999; Kops et al., 1999) . Phosphorylation of Bad promotes cell survival by preventing Bad from binding and inhibiting antiapoptotic Bcl-xL. Phosphorylation of forkhead transcription factor leads to its retention in the cytoplasm, thereby silencing its transcriptional activity and suppressing the expression of apoptotic genes, such as the gene that encodes the Fas ligand. Akt also affects cell cycle progression by regulating the cyclin D protein level (Diehl et al., 1998) , by phosphorylating Mdm2 (Zhou et al., 2001b) , p21 WAF1 (Zhou et al., 2001a) , p27
Kip1 (Fujita et al., 2002; Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002) or by regulating the forkhead transcription factor FOXO4-p27 pathway (Medema et al., 2000) . Akt blocks glycogen synthase kinase 3 beta (GSK3b)-mediated cyclin D nuclear exporting and degradation. Akt-mediated phosphorylation of Mdm2 promotes nuclear localization of Mdm2 and inhibits interaction between Mdm2 and p19ARF, thereby decreasing p53 stability. Phosphorylation of p27 Kip1 by Akt leads to the retention of p27 Kip1 in the cytoplasm, segregating this cyclin-dependent kinase (CDK) inhibitor from cyclin-CDK complexes. Also, Akt phosphorylation of a forkhead transcription factor FOXO4 prevents FOXO4-mediated upregulation of p27
Kip1 (Medema et al., 2000) . Importantly, Akt activity is elevated in several types of human malignancy, including ovarian, breast, lung and thyroid cancers (Vivanco and Sawyers, 2002) . The kinase activity of Akt is constitutively activated in human cancer as a result of dysregulation of its regulators, including the tumor suppressor PTEN (Wu et al., 1998) and the amplification of the catalytic subunit of PI3K (Scheid and Woodgett, 2001) . It is likely that more Akt regulators exist. Here, we show that 14-3-3s is a negative regulator of Akt and inhibits Akt-mediated cytoplasmic retention of p27.
14-3-3s is a member of 14-3-3 family proteins that have critical roles in signal transduction pathways and cell cycle regulation (Aitken, 1995; Yaffe et al., 1997; Fu et al., 2000) . The 14-3-3 family is highly conserved over a wide range of mammalian species, including seven isotypes b, e, Z, g, t (also called y), z and s. Among the family members, 14-3-3s is unique. 14-3-3s was characterized as a human mammary epithelial-specific marker(HME1) (Prasad et al., 1992) that is downregulated in mammary carcinoma cells. 14-3-3s regulates the cell cycle by interacting with CDKs (Laronga et al., 2000) and serving as a target of p53 (Hermeking et al., 1997) and BRCA1 (Aprelikova et al., 2001; Yarden et al., 2002) . BRCA1 is a tumor suppressor for breast and ovarian cancers and has important roles in DNA repair and transcription (Albertsen et al., 1994; Miki et al., 1994) . Mutations identified in the C terminus of BRCA1 from patients with breast cancer cannot activate transcription of 14-3-3s (Aprelikova et al., 2001) , suggesting that the tumor-suppressive function of BRCA1 involves 14-3-3s. 14-3-3s sequesters cyclin B1/CDC2 complexes in the cytoplasm to cause G2 arrest in response to DNA damage (Chan et al., 1999; Laronga et al., 2000) . During this DNA damage process, 14-3-3s also positively regulates p53 stability and potentiates p53 transcriptional activity (Yang et al., 2003) . Also, downregulation of 14-3-3s can make primary human epithelial cells grow indefinitely in a single step without the need of exogenous oncogenes and/or oncoviruses, suggesting that this immortality caused by 14-3-3s inhibition may lead to tumor formation (Dellambra et al., 2000) . Importantly, 14-3-3s is downregulated in several types of cancer, including breast cancer (Ferguson et al., 2000) . Overexpression of 14-3-3s suppresses the anchorage-independent growth of several breast cancer cell lines (Laronga et al., 2000) . These observations suggest that the tumor suppressor function of 14-3-3s is compromised during tumorigenesis. However, the mechanisms of 14-3-3s's role in tumorigenesis and signal transduction have not been fully elucidated. Here, we show that 14-3-3s overexpression caused cell cyle arrest by upregulating p27. 14-3-3s-mediated p27 upregulation correlates with Akt inactivation. We show that 14-3-3s inhibits Akt-mediated acceleration of p27 turnover. 14-3-3s inhibits Akt-mediated p27 phosphorylation, thereby blocking Akt-mediated p27 cytoplasmic location. Also, 14-3-3s inhibits cell survival and tumorigenicity of Akt-activating breast cancer cell. Accordingly, our studies in human breast cancers show that low expression of 14-3-3s is associated with cytoplasmic localization of p27, providing a mechanistic role for 14-3-3s downregulation in breast cancer formation.
Results

14-3-3s-mediated p27 upregulation correlates with Akt inactivation
We previously showed that 14-3-3s acts as a negative regulator of the cell cycle in several breast cancer cell lines (Laronga et al., 2000) . We further assayed whether 14-3-3s's inhibitory activity can affect the cell cycle of a normal lung epithelial cell line (R1B/L17). We subjected uninfected cells (control) and cells infected with Ad-HA-14-3-3s or Ad-b-gal to fluorescence-activated cell sorting (FACS) analysis to investigate the cell cycle distribution. Cells infected with Ad-14-3-3s showed an increased G2/M population (25.8%) compared with control (8.5%) and Ad-b-gal-infected cells (9.7%), showing that the expression of 14-3-3s results in cell cycle arrest in the G2/M phase ( Figure 1a) . p27 is an important CDK inhibitor and negative regulator of cell cycle . While investigating the negative regulatory role of 14-3-3s in cell cycle distribution, we found that the level of p27 was elevated after the introduction of increasing amounts of 14-3-3s via adenoviral transfer (Figure 1b) , suggesting that p27 is one of the effectors involved in 14-3-3s-mediated cell cycle inhibition. p27 is a substrate of Akt, and Akt phosphorylates p27 to induce localization of p27 to the cytoplasm (Fujita et al., 2002; Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002) , thus Immunoblot analysis of 14-3-3s, p27 expression, Akt-phosphorylated substrates,and Akt in R1B/L17 cells infected with Ad-b-gal (C), or Ad-14-3-3s at different multiplicities of infection. 14-3-3s is HA-tagged. (c) Immunoblot analysis of 14-3-3s, p27 expression, Akt-phosphorylated substrates and Akt in transfected R1B/L17 cells. Cells were transfected with equal amounts of p27 expression vector, CA-Aktexpressing vector and increasing amounts of the Flag-tagged 14-3-3s expression vector. Cell extracts were subjected to immunoblot analysis.
14-3-3r stabilizes p27 in cell cycle arrest H Yang et al enhancing p27 degradation . It is possible that Akt is regulated when 14-3-3s causes p27 elevation. To address this hypothesis, we first examined whether Akt activity is downregulated in response to increasing expression of 14-3-3s. Indeed, when the amount of 14-3-3s was increased, levels of the phosphorylation of Akt substrates decreased (Figure 1b) , suggesting that 14-3-3s affected endogenous Akt's kinase activity toward its substrates. We confirmed this observation in cells transfected with constitutively active Akt (CA-Akt, myristaylated), p27 and increasing amounts of 14-3-3s:
The exogenous constitutively active Akt's activity toward substrates was abrogated in the presence of 14-3-3s ( Figure 1c ). Together, these data indicated that 14-3-3s affected the activity of both endogenous and exogenous Akt. As expected, p27 is stabilized when Akt activity is diminished and when 14-3-3s is upregulated. Thus, compelling evidence suggests that 14-3-3s may stabilize the expression of p27 via inhibiting the activity of Akt.
14-3-3s reduces the turnover rate of p27 in Akt-activating cells To address the hypothesis that 14-3-3s can inhibit the activity of Akt to stabilize p27, we first examined whether Akt activity is causing the downregulation of p27. Because increased levels of p27 concurred with decreased phosphorylation of Akt substrates (i.e., decreased Akt activity), we inferred that high Akt activity leads to decreased stability of p27. We determined the protein stability of p27 by cycloheximide treatment in isogenic cell lines with different Akt status, including Akt-activating cells (Rat1-akt) and non-Aktactivating cells (Rat1). The results showed that the turnover rate of p27 was faster in Rat1-akt cells than in Rat1 cells (Figure 2a ), confirming that Akt activation results in p27 destabilization. We then used these two isogenic cell lines with different Akt status as a model to determine 14-3-3s's impact on Akt activation and p27 stabilization. To this end, we use adenoviral delivery of 14-3-3s. Both Rat1 Figure 2 14-3-3s reduces Akt-mediated acceleration of p27 turnover rate. (a) Comparision of p27 turnover in Rat1 and Rat1-akt cells. Rat1 and Rat1-akt cells were treated with the cycloheximide (100 mg/ml) for the indicated times. Cell lysates were immunoblotted with anti-p27. Levels of p27 at each time point were measured using a densitometer. The remaining level of p27 at time 0 was set at 100%. p27 remaining is indicated graphically. (b) Levels of 14-3-3s, p27, S473 phosphorylation of Akt in infected Rat1 and Rat1-akt cells. Rat1 and Rat1-akt cells were infected with Ad-b-gal (MOI ¼ 10), Ad-14-3-3s (MOI ¼ 10) or without virus (C). 14-3-3s is HAtagged. Cell extracts were subjected to immunoblot analysis with indicated antibodies. Cell extracts were also immunoprecipitated with anti-Akt and assayed for Akt kinase activity using glycogen synthase kinase 3 beta (GSK3b) as substrate. Autoradiographs show the 32 P-labeled GSK3b bands. (c) Immunoblots of p27 turnover in both Rat1 and Rat1-akt cells after Ad-14-3-3s infection. Rat1 and Rat1-akt cells were infected with Ad-b-gal (control, MOI ¼ 5) or Ad-14-3-3s (MOI ¼ 5) for 12 h, followed by the cycloheximide (100 mg/ml) treatment for the indicated times. 14-3-3s is HA-tagged. Cell lysates were immunoblotted with anti-p27 and anti-HA. (d) Comparision of p27 turnover in Ad-14-3-3s-infected cells. Levels of p27 at each time point in (c) were measured using a densitometer. The remaining level of p27 at time 0 was set at 100%. p27 remaining is indicated graphically.
14-3-3r stabilizes p27 in cell cycle arrest H Yang et al and Rat1-akt cells were infected with Ad-HA-14-3-3s or Ad-b-gal, or left uninfected. We found that T308 and S473 phosphorylation of Akt was inhibited by the adenoviral delivery of 14-3-3s in Rat1-akt cells that express constitutively active Akt (Figure 2b ). In these experiments, the p27 protein level was significantly increased following the expression of 14-3-3s. Rat1 cells infected with Ad-HA-14-3-3s also has reduced Akt activity as demonstrated by Akt-associated GSK3b kinase assay (Figure 2b ), thus having increased levels of p27 when compared with Ad-b-gal-infected cells. Because increased levels of p27 concurred with decreased S473 phosphorylation of Akt or decreased Akt activity in the presence of 14-3-3s, we inferred that 14-3-3s-mediated inhibition of Akt activity leads to increased levels of p27.
To investigate if the increased levels of p27 are a result of decreased turnover rate of p27, we determined the turnover rate of p27 by cycloheximide treatment. Again, both Rat1 or Rat1-akt cells were infected with Ad-b-gal (control) or Ad-14-3-3s. We found that the turnover rate of p27 was slower in cells infected with Ad-14-3-3s than in cells infected with Ad-b-gal ( Figure 2c and d), suggesting that 14-3-3s expression caused the decreased turnover rate of p27.
14-3-3s inhibits Akt-mediated p27 phosphorylation To further address the link of Akt inactivation with p27 stabilization, we treated the Rat1-akt cells with an Akt inhibitor. LY 294002, a specific inhibitor of PI3K, can inhibit Akt in Rat1-akt cells, as demonstrated by decreased Akt phosphorylation at Ser473 (Figure 3a) . Importantly, the levels of p27 expression were much higher in the LY 294002-treated Rat1-akt cells in comparison to the untreated cells (Figure 3a) , suggesting that the inhibition of Akt stabilizes the expression of p27.
Akt can phosphorylate threonine 157, 198 of human p27 (Fujita et al., 2002; Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002) , thereby enhancing p27 degradation. We investigate whether 14-3-3s can block Akt-mediated human p27 phosphorylation. R1B/L17 cells were infected with Ad-HA-14-3-3s or Ad-b-gal (control). Akt was immunoprecipitated and assayed for its activity to phosphorylate recombinant GSK3 b or human p27 substrate. The Akt-mediated GSK3 b and p27 phosphorylation of Ad-b-gal-infected cells was normal, but that of Ad-HA-14-3-3s-infected cells was severely reduced (Figure 3b ), indicating that 14-3-3s inhibits Akt kinase activity toward GSK3 b and human p27. Interestingly, Ad-HA-14-3-3s-infected cells also Figure 3 14-3-3s inhibits Akt-mediated p27 phosphorylation. (a) Phosphatidylinositide 3-OH kinase (PI3K)-Akt inhibitor stabilizes p27 expression in Rat1-akt cells. Cells were treated with ( þ ) or without (À) PI3K inhibitor LY294002 (10 mM). In all, equal amounts of protein from cell lysates were immunoblotted with anti-p27 and anti-tubulin. Phosphorylation of the S473 residue of Akt is also indicated. Tubulin served as a loading control. (b) 14-3-3s inhibits Akt-mediated p27 phosphorylation. Kinase assay performed with immunoprecipitated Akt or CDK2 from R1B/L17 cells infected with Ad-Ad-b-gal or Ad-14-3-3s. Cell lysates immunoprecipitated with control IgG were used as negative control for kinase assay. Purified recombinant glycogen synthase kinase 3 beta (GSK3b) and Flag-tagged human p27 served as substrates for an Akt kinase assay. Histone H1 served as a substrate for immunoprecipitated CDK2. Autoradiographs show the 32 P-labeled GSK3b, p27 and histone H1 bands. (c) 14-3-3s inhibits Akt-mediated p27 phosphorylation in vitro. Baculovirus-produced active recombinant Akt1 was incubated with indicated amounts of bacterially produced and purified recombinant 14-3-3s protein for kinase activity against recombinant p27 substrate. Autoradiographs show the phosphorylated p27 bands. (d) Akt-mediated phosphorylation of p27 mutants. Active recombinant Akt1 phosphorylates indicated bacterially produced and purified recombinant human p27 mutant proteins at different incubation times in an in vitro kinase assay. Autoradiographs show the phosphorylated bands. (e) Effects of 14-3-3s on Akt-mediated phosphorylation of p27 mutants. Recombinant Akt1 was also incubated with increased amounts of bacterially produced and purified recombinant 14-3-3s for kinase activity against indicated equal amounts of recombinant human p27 mutant proteins for 60 min. Phosphorylated signals of p27 mutant proteins were quantitated by phosphoimager. The phosphorylation level of human p27 mutant proteins in the absence of 14-3-3s was set at 100%. Relative % of phosphorylation is indicated graphically.
14-3-3r stabilizes p27 in cell cycle arrest H Yang et al had decreased Cdk2-associated histone H1 kinase activity (Figure 3b ), which may reflect the impact of increasing amounts of p27.
To further confirm the negative regulation of Akt kinase activity by 14-3-3s in a defined system, we incubated recombinant Akt, which is activated (T308D, S473D), with increasing amounts of purified 14-3-3s for kinase activity against purified recombinant wild-type human Flag-p27 substrate. 14-3-3s inhibited Aktmediated human p27 phosphorylation in a dosedependent manner (Figure 3c) . Also, 14-3-3s was not phosphorylated during the kinase assay (Figure 3c ). These results indicated that 14-3-3s directly inhibited Akt kinase activity toward p27 substrate and was not a competitive substrate for Akt.
It is clear that 14-3-3s inhibits Akt-mediated p27 phosphorylation. Akt can phosphorylate human p27 on Thr157 and Thr198 (Fujita et al., 2002; Shin et al., 2002) . To determine whether the Akt phosphorylation site of human p27 is inhibited, we performed in vitro kinase experiment using human p27 phosphorylation mutant. Ser10, Thr157 or Thr198 are potential phosphorylation sites (Ishida et al., 2000) , but we particularly focused on two well-characterized sites: T157 and T198. We performed the kinase experiment using two human p27 phosphorylation mutants, including p27 S10AT198A and p27 S10AT157A. We found that both mutants can be phosphorylated by Akt (Figure 3d ), indicating that either T198 or T157 is the Akt-dependent phosphorylation site. Importantly, 14-3-3s inhibits Aktmediated phosphorylation toward these two sites in a dose-dependent manner (Figure 3e ), suggesting that Akt-mediated phosphorylation on T157 or T198 of p27 is inhibited by 14-3-3s.
14-3-3s blocks Akt-mediated p27 cytoplasmic location Akt causes the cytoplasmic localization of some of its substrates to exert its biological function, including p27 (Fujita et al., 2002; Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002) . Akt phosphorylates p27, and causes nuclear export of p27. Because 14-3-3s inhibits Akt-mediated p27 phosphorylation, we determined whether 14-3-3s's inhibitory activity toward Akt blocks Akt-mediated p27 nuclear exporting. Rat1 and Rat-akt cells were infected with Ad-HA-14-3-3s or Ad-b-gal or left uninfected (control) for subcellular localization study using immunofluorescence staining. We found that p27 was cytoplasmic in control and Ad-b-galinfected Rat1-akt cells ( Figure 4a ). As expected, p27 was nuclear in Rat1 cells under these two conditions (Figure 4b ). The data confirmed that Akt's activity is Figure 4 14-3-3s blocks Akt-mediated p27 nuclear export. (a) Effects of 14-3-3s on Akt-mediated p27 nuclear exporting. The Rat1-akt cells were infected with Ad-HA-14-3-3s, or Ad-b-gal, or left uninfected (control). 14-3-3s is HA-tagged. After 48 h, cells were fixed and stained with anti-p27 to detect the location of p27 (red) or stained with anti-HA antibodies to observe the location of 14-3-3s (green). Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI) dye. (b) Effects of 14-3-3s on p27 subcellular localization in Rat1 cells. The Rat1 cells were infected with Ad-HA-14-3-3s or Ad-b-gal, or left uninfected (control). 14-3-3s is HA-tagged. After 48 h, cells were fixed and stained with anti-HA antibodies to observe the location of 14-3-3s (red) and anti-p27 to detect the location of p27 (green). Merged staining of the two proteins is also indicated. (c) Effects of 14-3-3s on Akt subcellular localization. The Rat1-akt cells were infected with Ad-HA-14-3-3s or Ad-b-gal, or left uninfected (control). 14-3-3s is HA-tagged. After 48 h, cells were fixed and stained with anti-HA antibodies to observe the location of 14-3-3s (green) and anti-Akt to detect the location of Akt (red). Nuclei were stained with DAPI dye.
14-3-3r stabilizes p27 in cell cycle arrest H Yang et al involved in regulating p27 localization. Importantly, p27 cytoplasmic location was dramatically reduced in Ad-HA-14-3-3s-infected Rat1-akt cells, suggesting that 14-3-3s inhibits the Akt-mediated cytoplasmic location of p27 ( Figure 4a ). As expected, 14-3-3s did not affect the nuclear location of p27 in Rat1 cells (Figure 4b ). During this study, the localization of Akt in Rat1-akt was not changed by the infection of Ad-HA-14-3-3s or Ad-b-gal (Figure 4c ). Taken together, these results indicate that 14-3-3s can specifically inhibit Akt-mediated p27 nuclear export.
14-3-3s inhibits cell survival and tumorigenicity of Akt-activating breast cancer cell Akt has been implicated in the control of cell survival. For example, mice with targeted disruption of the Akt1 gene are more sensitive to apoptosis-inducing stimuli (Chen et al., 2001) . Also, Akt is highly activated in some breast cancer cells. To assess the biological consequences of the impairment of Akt activity by 14-3-3s in breast cancer cells, we investigated whether 14-3-3s could inhibit cell proliferation and specifically block the Akt-mediated survival activity in breast cancer cells. Uninfected cells were used as controls (C). MDA-MB-361 cells were also treated with 2-methoxyestradiol at the indicated concentrations. Induced apoptosis was determined by measuring DNA fragmentation using the cell death ELISA kit (Roche). The results were expressed as the value of A 405 reading. The absorbance (OD) is directly proportional to the apoptosis. Bars, s.d. The average of three independent experiments (7s.e.) is shown. ELISA agents only were used as negative controls. (e) 14-3-3s inhibited the tumorigenicity of Akt-activating breast cancer cells. MDA-MB-361 cells were infected with the indicated recombinant adenoviruses. Cells were injected into the mammary fat-pads of 6-week-old female nude mice. Tumor volumes were monitored at regular intervals for 80 days. The data represent the mean value of six treated mice with the s.d.
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Human breast cancer cell line MDA-MB-361, which has activated Akt and low levels of p27 comparable to Rat1-Akt cells (Figure 5a ), is used for further study. Because of the 14-3-3s's positive impact on p27 stabilization (Figure 5b ), we first measured the cell proliferation of MDA-MB-361 in the presence of 14-3-3s overexpression. We determined the cell growth using a 3-(4-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (MTT assay). The growth rate of MDA-MB-361 cells infected with Ad-14-3-3s decreased drastically after the infection (Figure 5c ). In contrast, neither controls nor Ad-b-gal-infected cells had reduced growth rate. Because 14-3-3s inhibits Akt activation and may antagonize Akt-mediated cell survival, we then determined the14-3-3s-induced apoptosis in MDA-MB-361 cells. We infected the cells with Ad-14-3-3s at various multiplicities of infection (MOIs). We measured apoptosis by quantitating DNA fragmentation. 14-3-3s overexpression resulted in apoptosis in MDA-MB361cells (Figure 5d ). Moreover, we investigated whether 14-3-3s increased the efficiency of apoptosis induced by 2-methoxyestradiol (2-ME), a new anticancer agent that inhibits superoxide dismutase and induces apoptosis in cancer cells (Huang et al., 2000) . 14-3-3s or 2-ME alone caused apoptosis. Significantly, MDA-MB-361 cells treated with both agents showed a twofold increase in DNA fragmentation over cells treated with only single agent (Figure 5d ), indicating that 14-3-3s sensitized cells to apoptosis induced by 2-ME. Thus, 14-3-3s promoted apoptosis and potentiated the apoptotic effect of 2-ME in human breast cancer cells containing activating Akt.
The impact of 14-3-3s on tumorigenicity in vivo was then examined in xenograft tumor models. MDA-MB-361 cells were left uninfected (control) or infected with Ad-HA-14-3-3s or Ad-b-gal, and cells were then implanted into nude mice. We monitored the tumor growth for 80 days. Control mice and Ad-b-gal-treated mice (Figure 5e ) had large tumors; however, tumor volume was dramatically reduced in Ad-HA-14-3-3s-treated mice, suggesting that 14-3-3s can also inhibit tumorigenicity in a human breast cancer cell line containing activated Akt.
Downregulation of 14-3-3s correlates with p27 cytoplasmic localization in breast cancers 14-3-3s is downregulated in many types of cancer, including breast cancer (Ferguson et al., 2000) . To further investigate the crossregulation between 14-3-3s and cytoplasmic p27 location in vivo, we investigated the expression of 14-3-3s and subcellular localization of p27 in 37 primary breast cancer tissue using immunohistochemistry. We found a strong inverse relationship between 14-3-3s expression and the cytoplasmic p27 location ( Figure 6 and Table 1 ). In tumors, in which 14-3-3s expression is low, p27 location is in the cytoplasm (representative Case I in Figure 6 ), whereas in tumors in which 14-3-3s expression is high, p27 location is in the nucleus (representative Case II in Figure 6 ). We concluded that specimens with low 14-3-3s protein expression showed a large percentage of cytoplasmic p27 staining in tumor cells.
Discussion
The high frequency of downregulation of 14-3-3s in several types of cancer demonstrates that the dysregulation of 14-3-3s plays an important role in human tumorigenesis. Akt also plays a pivotal role in cancer formation, and its oncogenic activity arises from the activation of both proliferative and antiapoptotic signaling. Obviously, Akt is an important molecular target for rational cancer therapy. This study shows that 14-3-3s can inhibit Akt-mediated p27 phosphorylation, thereby stabilizing p27 protein. This important biological function blocks the Akt-mediated cytoplasmic location of p27 to correct mitogenic cell growth. Consistent with the observation, primary breast cancer studies showed that downregulation of 14-3-3s results in the cytoplasmic location of p27. Importantly, overexpression of 14-3-3s inhibits tumorigenicity of breast cancer cells with high Akt activity in cancer models. Thus, as a Akt negative regulator involved in stabilizing Figure 6 Low 14-3-3s expression correlates with cytoplasmic expression of p27 in primary invasive breast carcinomas. Immunohistochemical studies of primary breast adenocarcinomas are shown. Human primary breast cancer tissues were immunostained with anti-14-3-3s and anti-p27 antibodies. Representative tissue sections from tumor I, a low 14-3-3s-expressing ductal carcinoma containing a high level of p27 in the cytoplasm. Representative sections from tumor II, a 14-3-3s-abundant ductal carcinoma containing a high level of p27 in the nucleus. 14-3-3r stabilizes p27 in cell cycle arrest H Yang et al p27, 14-3-3s should prove useful in the treatment of tumors with elevated Akt activity and mislocated p27.
One particular interesting observation is that 14-3-3s stabilizes the expression of p27 when it antagonizes the kinase activity of Akt at the same time (Figure 1b) . Recombinant 14-3-3s inhibits Akt kinase activity toward p27 in a dose-dependent manner (Figure 3c ), confirming that 14-3-3s is an inhibitor of Akt. Indeed, we found that 14-3-3s asoociates with Akt in vitro and in vivo (Yang et al., 2006a) . Also, we have shown that 14-3-3s could directly interact with Akt and inhibit Akt's activity (Yang et al., 2006a) . Remarkably, 14-3-3s but not other isforms of 14-3-3 (g, t, z) inhibits Aktmediated kinase activity (Yang et al., 2006a) , suggesting that 14-3-3s is specific in inhibiting Akt and that 14-3-3s and other 14-3-3 members are not equivalent functionally. We show that Thr308 and Ser473 phosphorylation of Akt was inhibited by the adenoviral delivery of 14-3-3s into cells. Recently, rictor-mTOR complex can phosphorylate Akt/PKB on Ser473 and facilitate Thr308 phosphorylation by PDK1 (Sarbassov et al., 2005) , thereby promoting cell proliferation. Also, DNA-PK phosphorylates PKB on Ser473 (Feng et al., 2004) , enhancing Akt activity. Whether 14-3-3s has any impact on rictor-mTOR or DNA-PK activity to regulate Akt remains to be investigated.
Because Akt phosphorylates p27 and causes cytoplasmic mislocation and subsequent degradation of p27 (Fujita et al., 2002; Shin et al., 2002) , it is conceivable that 14-3-3s's negative impact on Akt will lead to the decrease of Akt-mediated p27 phosphorylation, and in turn keeps p27 in the nucleus. In cells, Akt-mediated human p27 phosphorylation at Thr157 (within the nuclear localization signal (NLS) sequence of p27, aa 153-166) results in impairing the nuclear import of p27 (Shin et al., 2002) . Importin a is responsible for binding p27 NLS, thus transporting p27 into the nucleus (Sekimoto et al., 2004) . Interestingly, several 14-3-3 isoforms (b, z, g, y and e) except 14-3-3s can compete with importin a to bind phophorylated Thr157 in NLS (Sekimoto et al., 2004) , thus sequestering p27 in the cytoplasm. In addition, Akt also phosphorylates human p27 at Thr198 (Fujita et al., 2002) , which also results in the nuclear export and degradation of p27. It has been shown that 14-3-3y, Z and e proteins (not 14-3-3s) bind to p27 through phophorylated Thr198 to sequester p27 in the cytoplasm (Fujita et al., 2002) . Thus, it is important to point out that other 14-3-3 isotypes participate in Akt-mediated cytoplasmic location of p27. In contrast, 14-3-3s blocks Akt-mediated p27 phosphorylation and facilitates p27 nuclear import, which is consistent with its role as a negative regulator of the cell cycle.
Various human tumors, including breast cancer, have a cytoplasmic mislocation of p27 (Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002) . One of the mechanisms responsible for the altered subcellular localization of p27 is mediated by Akt activity. Akt activation correlates with p27 phosphorylation and the cytoplasmic mislocation of p27 in breast cancer (Viglietto et al., 2002) . Importantly, p27 mislocation is associated with poor patient outcome (Liang et al., 2002) . In our primary breast cancer sample studies, we showed that cytoplasmic accumulation of p27 concurred with reduced expression of 14-3-3s. Because Akt activation also correlated with lower expression of 14-3-3s (Yang et al., 2006a) , and with the cytoplasmic accumulation of p27 (Figure 4) , we propose a model (Figure 7 ) whereby the reduced expression of 14-3-3s leads to increased Akt-meditaed p27 phosphorylation and, as a consequence, the cytoplasmic location of p27 and the impairment of its inhibitory activities toward cyclin-CDK complexes, thereby promoting cancer development.
We previously demonstrated that p27 or modified p27 proteins (Yang HY et al., 2006) , which are designed to be retained in the nucleus, have Figure 7 Model for the effects of 14-3-3s in regulating p27 stability via inhibiting Akt.
14-3-3r stabilizes p27 in cell cycle arrest H Yang et al tumor suppressive activity. On the basis of positive impact of 14-3-3s toward p27 in the presence of activated Akt, we propose that 14-3-3s has tumorsuppressive activity in Akt-activated cancer cells. Our studies indicated that 14-3-3s inhibited the tumorigenicity of human breast cancer cells with activated Akt (Figure 5e ), highlighting the tumor-suppressive role of 14-3-3s. In the human breast cancer model, 14-3-3s-mediated p27 upregulation could, at least in part, contribute to tumor suppression. Of course, inhibition of Akt-mediated cell survival (Figure 5d ) and Aktmediated Mdm2 phosphorylation (Zhou et al., 2001b) (Figure 7 ) by 14-3-3s may play roles in tumor suppression. In addition, it was noted that Skp2 binds to phosphorylated p27, which is phosphorylated on Thr187 by CDK2, and this facilitates the ubiquitinmediated degradation of p27 (Carrano et al., 1999) . We previously showed that 14-3-3s can also interact and inhibit CDK2 (Laronga et al., 2000) , which in turn will impair phosphorylation on Thr187 of p27 and lead to decreased p27 ubiquitination. Thus, 14-3-3s's growth inhibitory activity can be excuted through regulating p27 stability, antagonizing CDK activity or both, resulting in tumor suppression. Our tumor studies indicate that downregulation of 14-3-3s correlates very well with the lower expression of p27 and the activation of Akt. Given that both p27 and Akt are deregulated in several types of cancers, our findings in defining the role of 14-3-3s in blocking Aktmediated p27 degradation and in exploring 14-3-3s as an anticancer agent have important clinical relevance. Recently, we showed that 14-3-3s is efficient in inhibiting the tumorigenicity of ErbB2-overexpressing cells (Yang et al., 2003) , Akt-activating cells (Yang et al., 2006a) and nasopharyngeal carcinma cells (Yang et al., 2006b) . These data provide compelling evidence that 14-3-3s can function as a tumor suppressor. Targeting Akt by the administration of 14-3-3s could be an excellent therapeutic regimen for the treatment of cancers in which the PI3K-Akt pathway is constitutively activated, including cancer cells with the mutations of the PTEN tumor suppressor.
Materials and methods
Cell lines, viruses, plasmids, kinase inhibitors and antibodies R1B/L17 (the mink lung epithelial cell line) (Lee et al., 1995) , Rat-1 cells, MDA-MB-361 cells and Rat1-akt cells (Binhua Zhou, MD Anderson Cancer Center) were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. Ad-14-3-3s and Ad-Ad-b-gal viruses (Hermeking et al., 1997) were produced as described previously (He et al., 1998) . Plasmids of p27 S10AT198A and p27 S10AT157A were constructed by PCR cloning using designed primers with mutations at the target sites. PCR products were cloned into pET 11d (Novagene, Madison, WI, USA) vectors and sequenced. All recombinant p27 proteins were Flag-tagged and were bacterially produced by using expression vector pET11d and purified as described (Lee et al., 1995) . LY294002 was from Biomol (Plymouth Meeting, PA, USA). Cycloheximide and 2-ME were from Sigma (St Louis, MO, USA). For immunoprecipitation and immunoblotting, the following antibodies were used: monoclonal antibodies against FLAG, HA (12CA5, Babco, Richmond, CA, USA), tubulin from Sigma (St Louis, MO, USA); antibodies against Akt, phosphoAkt (Ser473 or Thr308) 4E2, phospho-(Ser/Thr) Akt substrate antibody from Cell Signaling; antibody against p27 from ZYMED (Carlsbad, CA, USA) and antibody against 14-3-3s from RDI.
Kinase assays R1B/L17 cells were either left uninfected or infected with Ad-14-3-3s (MOI ¼ 5) or Ad-b-gal (MOI ¼ 5). Cell lysates were immunoprecipitated with anti-Akt or anti-CDK2. Immunoprecipitated complexes were incubated with 0.04 mg GSK3b (Cell Signaling) or 1 mg of Flag-p27 (bacterially produced by using expression vector pET21a (Novagene) and purified as described (Lee et al., 1995) ) or 50 mg/ml histone H1 with 10 mCi [g-32 P]ATP (Amersham, Arlington Heights, CL, USA) for a kinase assay as described . In other in vitro kinase assays, 1 ml of baculovirus-produced active recombinant Akt1 (Cell Signaling), which is activated (T308D, S473D) and is isolated and purified from Sf9 cells, was incubated with purified recombinant 14-3-3s for kinase activity against recombinant wild-type Flag-p27 or Flag-p27 mutants (bacterially produced by using expression vector pET11d and purified) in the presence of 10 mCi [g-32 P]ATP. Phosphorylated substrate was visualized or quantitated using a STORM840 PhosphorImager.
Immunofluorescence Rat1-akt cells were treated with Ad-HA-14-3-3s (MOI ¼ 5) or Ad-b-gal (MOI ¼ 5) and compared with nontreated (PBS control). Cells were then fixed with methanol/acetone (1:1 v/v) at room temperature for 2 min and stained for 1 h with rabbit anti-p27 followed by 1 h of incubation with Alexa 568-conjugated anti-rabbit antibody (Molecular Probes, Carlsbad, CA, USA). For studying the subcellular localization of exogenous 14-3-3s, cells were stained with anti-HA monoclonal antibody (12CA5, Babco), followed by the Alexa 488-conjugated anti-mouse secondary antibody (Molecular Probes). Another set of cells was stained with rabbit anti-Akt followed by incubation with Alexa-568-conjugated anti-rabbit antibody whereas the staining for 14-3-3s was the same. For all staining, the cells were incubated with 0.1 mg/ml of 4,6-diamidino-2-phenylindole (DAPI) (Sigma) to stain the nuclei. For localization of 14-3-3s in Rat1 cells treated with Ad-HA-14-3-3s (MOI ¼ 5) or Ad-b-gal (MOI ¼ 5) and PBS control, cells were stained with anti-HA monoclonal antibody (12CA5, Babco), followed by the Alexa 568-conjugated antimouse secondary antibody (Molecular Probes). The subcellular localization of p27 was determined by staining with rabbit anti-p27 followed by the Alexa 488-conjugated antirabbit secondary antibody (Molecular Probes). Immunofluorescence was detected using an Axioplan 2 fluorescence microscope (Zeiss).
3-(4-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and fluorescence-activated cell sorting assay MDA-MB-361 cells or R1B/L17 cells were infected with Ad-HA-14-3-3s (MOI ¼ 5) or Ad-b-gal (MOI ¼ 5) and compared with untreated cells (PBS control) for the assays. These assays were performed as described .
Apoptosis assays MDA-MB-361 cells were treated with Ad-HA-14-3-3s (MOI ¼ 2.5 or 5), Ad-b-gal (MOI ¼ 2.5 or 5) or apoptotic stimulus (3 or 10 mM 2-ME) and compared with nontreated cells (PBS control). After induction of apoptosis, floating and attached cells were harvested 16 h after the treatment. Cells were lysed at room temperature for 30 min, and dilutions of these extracts were used for the cell death ELISA, which was performed as described previously (Zhang et al., 2004) and according to the manufacturer's protocol (Roche).
Tumor growth in nude mice
Female 4-to 5-week-old nude mice (Charles River Laboratories, Wilmington, MA, USA) were divided into three experimental groups, six for each. MDA-MB-361 cells were left uninfected (control) or infected with Ad-b-gal (MOI ¼ 5) or Ad-14-3-3s (MOI ¼ 5) for 48 h. 2 Â 10 6 cells were harvested and injected subcutaneously into the mammary fat pad of mice. Tumor volumes were measured as described . Tumor volumes were measured every 2 days from day 3 of cell inoculation for 80 days.
Immunohistochemistry Sections from paraffin blocks of 37 invasive breast tumors were deparaffinized in serial grades of xylene followed by rehydration in sequential increasing dilutions of ethanol. Antigen retrieval was facilitated by heating in 10 M Na citrate buffer, pH 6.0. Slides were incubated with 14-3-3s (C-18) (Santa Cruz Biotechnology, Santa Cruz, CA, USA, 1:50, room temperature, 1 h) and p27
Kip1 (Cell Signaling, 1:100, 41C, 1 h). The general immunohistochemical staining scheme was performed as described previously (Newman et al., 2001) . Antibody detection was performed with the ABC substrate kit (Vector Laboratories, Burlingame, CA, USA), and slides were counterstained with hematoxylin. Statistical comparisons were carried out using Fisher's exact test.
